News|Articles|October 31, 2024
Robust Oligonucleotide Molecular Weight Confirmation via LC/MS
Author(s)Agilent Technologies, Inc.
Oligonucleotides—therapeutic agents for difficult-to-treat diseases—rely on precise molecular weight confirmation to ensure quality during development. Experts from Agilent Technologies explore the challenges of liquid chromatography-mass spectrometry (LC/MS) analysis in oligonucleotide synthesis, as well as strategies for accurate deconvolution, method development, and optimal equipment selection.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Trending on LCGC International
1
High-throughput Headspace Analysis of Volatile Nitrosamines and their Secondary Amine Precursors
2
GC-IMS Profiling of Flavor and Quality Changes in Cooked Crayfish
3
Streamlined Method Development for Efficient and Reliable Lipid Nanoparticle Analysis
4
Forging a Path in Analytical Science
5
